Sunday, July 16, 2006 5:55:11 PM
Stem Cells This Morning
the sunday talk shows were discussing the stem cell debate in the Senate this morning. The concensus was that the bill would pass and that Bush would veto. Some thought that Bush was setting himself and by association the RNC as being anti-science and that this stance by him would hurt the RNC badly in the mid terms since Americans in the vast majority identify America as the ideal for progress through science.
The biggest problem with Bush, as I see it, for the future will be the IND for testing hESC's on the spinal injury patients. I think we have all seen how the FDA has been co-opted on drugs that have some distaste to the RR, i.e. the morning after pill, RU486, and even more unbelievably the HPV vaccine. We should all be prepared to start as massive as possible of a writing compaign to assure that congress puts maximum pressure on the FDA to stick to the science and stay away from the religious issues that may be brought up.
the sunday talk shows were discussing the stem cell debate in the Senate this morning. The concensus was that the bill would pass and that Bush would veto. Some thought that Bush was setting himself and by association the RNC as being anti-science and that this stance by him would hurt the RNC badly in the mid terms since Americans in the vast majority identify America as the ideal for progress through science.
The biggest problem with Bush, as I see it, for the future will be the IND for testing hESC's on the spinal injury patients. I think we have all seen how the FDA has been co-opted on drugs that have some distaste to the RR, i.e. the morning after pill, RU486, and even more unbelievably the HPV vaccine. We should all be prepared to start as massive as possible of a writing compaign to assure that congress puts maximum pressure on the FDA to stick to the science and stay away from the religious issues that may be brought up.
Recent GERN News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/07/2026 08:31:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/07/2026 08:31:07 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/07/2026 08:30:34 PM
- Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/06/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 08:30:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 09:37:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 09:33:13 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 09:32:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 12:18:10 PM
- Geron Announces Appointment of New Members to its Board of Directors • GlobeNewswire Inc. • 03/26/2026 12:00:00 PM
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/18/2026 08:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/03/2026 09:30:02 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/02/2026 12:47:55 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 12:11:02 PM
- Geron shares drop after Q4 results miss estimates despite Rytelo growth • IH Market News • 02/25/2026 03:39:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:15:13 PM
- Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- Geron Plans to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 11:11:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 11:10:05 PM
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/18/2026 09:15:00 PM
- Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 • GlobeNewswire Inc. • 02/11/2026 12:27:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:00:26 PM
